Advertisement

To view this email as a web page, click here.

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

BIRTH CONTROL

TODAY'S HEADLINES

Two states to allow pharmacists to prescribe birth control

Pharmacists in California and Oregon will soon be able to prescribe birth control. Read more

Manufacturer-Foundation partnership to increase PF research

The Pulmonary Fibrosis Foundation and Boehringer Ingelheim’s 5-year partnership aims to raise awareness of pulmonary fibrosis (PF), provide disease education and advance care and funding research for the PF community – including patients with idiopathic pulmonary fibrosis. Read more

CONTINUING EDUCATION

November 2015
Recognition of drug-induced pulmonary disease and management of idiopathic pulmonary fibrosis

Session code: 15DT36-KXF58

This month's CE activity is part of the CPE series, "Medication Therapy Management for the Patient with Respiratory Disease." From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

December 11, 2015

Related Articles

Antidepressant use during pregnancy: 5 things to remember

Top 5 findings about IPF patients

EDITOR'S PICK

FDA OKs modified antihemophilic factor for hemophilia A

FDA has approved recombinant, PEGylated Antihemophilic Factor (Adynovate, Baxalta) for use in patients who have hemophilia A. Details

Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us